Baseline nutritional status z scores and risk of death
Model . | Variable . | Therapy . | Comparison . | Combined population . | ||||||
---|---|---|---|---|---|---|---|---|---|---|
HR . | 95% CI . | P value . | HR . | 95% CI . | P value . | HR . | 95% CI . | P value . | ||
Model 1: weight-for-age z score | Age | 0.912 | 0.700-1.118 | .494 | 0.912 | 0.677-1.156 | .546 | 0.886 | 0.729-1.076 | .222 |
Female | 1.244 | 0.431-3.592 | .687 | 0.839 | 0.215-3.266 | .800 | 1.151 | 0.514-2.578 | .733 | |
Hemoglobin (g/dL) | 1.343 | 0.679-2.656 | .396 | 0.595 | 0.704-2.714 | .190 | 0.873 | 0.546-1.396 | .570 | |
Weight-for-age z score | 0.593 | 0.300-0.956 | .032 | 0.610 | 0.321-1.158 | .131 | 0.580 | 0.399-0.843 | .004 | |
Model 2: height-for-age z score | Age | 0.929 | 0.713-1.211 | .586 | 0.976 | 0.719-1.323 | .875 | 0.916 | 0.756-1.111 | .373 |
Female | 1.450 | 0.509-4.133 | .487 | 0.669 | 0.178-2.507 | .551 | 1.108 | 0.495-2.479 | .804 | |
Hemoglobin (g/dL) | 1.275 | 0.640-2.543 | .490 | 0.563 | 0.253-1.248 | .157 | 0.864 | 0.535-1.396 | .551 | |
Height-for-age z score | 0.692 | 0.446-1.074 | .101 | 0.950 | 0.547-1.650 | .855 | 0.753 | 0.541-1.047 | .092 | |
Model 3: BMI z score | Age | 0.992 | 0.770-1.277 | .950 | 0.943 | 0.712-1.250 | .684 | 0.936 | 0.777-1.128 | .489 |
Female | 1.364 | 0.475-3.912 | .564 | 0.970 | 0.238-3.963 | .966 | 1.128 | 0.503-2.530 | .771 | |
Hemoglobin (g/dL) | 1.322 | 0.680-2.569 | .411 | 0.582 | 0.272-1.245 | .163 | 0.840 | 0.527-1.339 | .464 | |
BMI z score | 0.891 | 0.569-1.396 | .615 | 0.629 | 0.386-1.026 | .063 | 0.778 | 0.568-1.065 | .117 |
Model . | Variable . | Therapy . | Comparison . | Combined population . | ||||||
---|---|---|---|---|---|---|---|---|---|---|
HR . | 95% CI . | P value . | HR . | 95% CI . | P value . | HR . | 95% CI . | P value . | ||
Model 1: weight-for-age z score | Age | 0.912 | 0.700-1.118 | .494 | 0.912 | 0.677-1.156 | .546 | 0.886 | 0.729-1.076 | .222 |
Female | 1.244 | 0.431-3.592 | .687 | 0.839 | 0.215-3.266 | .800 | 1.151 | 0.514-2.578 | .733 | |
Hemoglobin (g/dL) | 1.343 | 0.679-2.656 | .396 | 0.595 | 0.704-2.714 | .190 | 0.873 | 0.546-1.396 | .570 | |
Weight-for-age z score | 0.593 | 0.300-0.956 | .032 | 0.610 | 0.321-1.158 | .131 | 0.580 | 0.399-0.843 | .004 | |
Model 2: height-for-age z score | Age | 0.929 | 0.713-1.211 | .586 | 0.976 | 0.719-1.323 | .875 | 0.916 | 0.756-1.111 | .373 |
Female | 1.450 | 0.509-4.133 | .487 | 0.669 | 0.178-2.507 | .551 | 1.108 | 0.495-2.479 | .804 | |
Hemoglobin (g/dL) | 1.275 | 0.640-2.543 | .490 | 0.563 | 0.253-1.248 | .157 | 0.864 | 0.535-1.396 | .551 | |
Height-for-age z score | 0.692 | 0.446-1.074 | .101 | 0.950 | 0.547-1.650 | .855 | 0.753 | 0.541-1.047 | .092 | |
Model 3: BMI z score | Age | 0.992 | 0.770-1.277 | .950 | 0.943 | 0.712-1.250 | .684 | 0.936 | 0.777-1.128 | .489 |
Female | 1.364 | 0.475-3.912 | .564 | 0.970 | 0.238-3.963 | .966 | 1.128 | 0.503-2.530 | .771 | |
Hemoglobin (g/dL) | 1.322 | 0.680-2.569 | .411 | 0.582 | 0.272-1.245 | .163 | 0.840 | 0.527-1.339 | .464 | |
BMI z score | 0.891 | 0.569-1.396 | .615 | 0.629 | 0.386-1.026 | .063 | 0.778 | 0.568-1.065 | .117 |
Multivariate Cox regression of factors associated with death among children with SCA in the SPRING Trial (n = 431). Separate models for height-for-age, weight-for-age, and BMI z scores.
Multivariate Cox regression models included age, sex, and hemoglobin at screening. The therapy group comprised children with abnormal transcranial Doppler velocities on hydroxyurea therapy, and the comparison group was children with nonelevated transcranial Doppler velocities.
Nutritional status is classified into weight-for-age, height-for-age, and BMI z scores using the WHO growth references.